Search

everythinglearnresearchcommunity

for

Search:↓

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Both botulinum toxin A and multivitamin mesotherapy effectively treat hair loss, with botulinum toxin A being the better single-session option.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

COVID-19 often causes hair loss, especially in women.

Traditional Ayurvedic treatment improved hair loss in a young woman.

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

People with Telogen Effluvium have similar zinc levels in their blood as healthy individuals.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 may cause temporary hair loss due to the body's immune response.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

UV rays can cause a type of hair loss known as telogen alopecia.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Higher Vitamin-D levels may help treat certain types of hair loss.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Vitamin D levels are not correlated with chronic hair loss in Telogen Effluvium patients.